Basic Stats
| LEI | 549300K6KY242XRMEF28 |
| CIK | 1651561 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Tabula Rasa HealthCare Inc
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 5)1 Tabula Rasa HealthCare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) Zac Ros |
|
| November 13, 2023 |
As filed with the Securities and Exchange Commission on November 13, 2023 As filed with the Securities and Exchange Commission on November 13, 2023 Registration No. |
|
| November 13, 2023 |
As filed with the Securities and Exchange Commission on November 13, 2023 As filed with the Securities and Exchange Commission on November 13, 2023 Registration No. |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-37888 Tabula Rasa HealthCare, Inc. (Exact name of registrant as specifi |
|
| November 13, 2023 |
As filed with the Securities and Exchange Commission on November 13, 2023 As filed with the Securities and Exchange Commission on November 13, 2023 Registration No. |
|
| November 13, 2023 |
As filed with the Securities and Exchange Commission on November 13, 2023 As filed with the Securities and Exchange Commission on November 13, 2023 Registration No. |
|
| November 13, 2023 |
As filed with the Securities and Exchange Commission on November 13, 2023 As filed with the Securities and Exchange Commission on November 13, 2023 Registration No. |
|
| November 13, 2023 |
As filed with the Securities and Exchange Commission on November 13, 2023 As filed with the Securities and Exchange Commission on November 13, 2023 Registration No. |
|
| November 13, 2023 |
As filed with the Securities and Exchange Commission on November 13, 2023 As filed with the Securities and Exchange Commission on November 13, 2023 Registration No. |
|
| November 13, 2023 |
As filed with the Securities and Exchange Commission on November 13, 2023 As filed with the Securities and Exchange Commission on November 13, 2023 Registration No. |
|
| November 13, 2023 |
As filed with the Securities and Exchange Commission on November 13, 2023 As filed with the Securities and Exchange Commission on November 13, 2023 Registration No. |
|
| November 6, 2023 |
Exhibit 3.2 SECOND AMENDED AND RESTATED BY-LAWS OF TABULA RASA HEALTHCARE, INC. A Delaware corporation (Adopted as of November 3, 2023) ARTICLE I OFFICES Section 1. Registered Office. The address of the corporation’s registered office in the State of Delaware is Registered Office Service Company, 614, N. DuPont Hwy, Suite 210, Dover, Kent County, Delaware 19901. The name of its registered agent at |
|
| November 6, 2023 |
Execution Version FIRST SUPPLEMENTAL INDENTURE Exhibit 4.1 Execution Version FIRST SUPPLEMENTAL INDENTURE FIRST SUPPLEMENTAL INDENTURE, dated as of November 3, 2023 (this “Supplemental Indenture”), between Tabula Rasa HealthCare, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association (as successor to U.S. Bank National Association), a national banking association organized under the laws of t |
|
| November 6, 2023 |
Exhibit 99.2 NOTICE TO HOLDERS OF TABULA RASA HEALTHCARE, INC. 1.75% CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2026 OF MERGER EVENT EXECUTION OF SUPPLEMENTAL INDENTURE FUNDAMENTAL CHANGE MAKE-WHOLE FUNDAMENTAL CHANGE CUSIP Number: 873379AA9 * Repurchase rights in connection with this notice expire at 5:00 p.m. (New York City time) on December 6, 2023. To the Holders of the 1.75% Convertible Senior |
|
| November 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 3, 2023 Tabula Rasa HealthCare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37888 46-5726437 (State or other jurisdiction of incorporation) (Comm |
|
| November 6, 2023 |
Exhibit 99.1 ExactCare and Tabula Rasa HealthCare Business Combination Closes, Creating a Leading, Independent Value-Based Pharmacy Management Company for Patients with the Most Complex Needs CLEVELAND (November 6, 2023) – ExactCare®, a national provider of medication management and comprehensive long-term pharmacy services and a Nautic Partners portfolio company, today announced that the acquisit |
|
| November 6, 2023 |
SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TABULA RASA HEALTHCARE, INC. ARTICLE ONE Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TABULA RASA HEALTHCARE, INC. ARTICLE ONE The name of the corporation is Tabula Rasa HealthCare, Inc. (hereinafter called the “Corporation”). ARTICLE TWO The address of the Corporation’s registered office in the State of Delaware is 251 Little Falls Drive, Wilmington, New Castle County, Delaware 19808. The name of its registere |
|
| November 3, 2023 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 3, 2023 Tabula Rasa HealthCare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37888 46-5726437 (State or other jurisdiction (Commission (I.R.S. Emp |
|
| October 31, 2023 |
Tabula Rasa HealthCare Stockholders Approve Acquisition by Nautic Partners Exhibit 99.1 Tabula Rasa HealthCare Stockholders Approve Acquisition by Nautic Partners MOORESTOWN, N.J., (DATE) - Tabula Rasa HealthCare, Inc.® (“TRHC” or the “Company”) (NASDAQ: TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based organizations, today announced that its stockholders approved the previously announced acquisition by Nautic Partners (“Nauti |
|
| October 31, 2023 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 31, 2023 Tabula Rasa HealthCare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37888 46-5726437 (State or other jurisdiction (Commission (I.R.S. Emp |
|
| October 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 19, 2023 Tabula Rasa HealthCare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37888 46-5726437 (State or other jurisdiction of incorporation) (Comm |
|
| October 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 19, 2023 Tabula Rasa HealthCare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37888 46-5726437 (State or other jurisdiction of incorporation) (Comm |
|
| September 29, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D |
|
| September 18, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ D |
|
| September 18, 2023 |
Exhibit 107 CALCULATION OF FILING FEE TABLES Schedule 14A (Form Type) TABULA RASA HEALTHCARE, INC. |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 4)1 Tabula Rasa HealthCare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) Zac Ros |
|
| August 8, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 Tabu |
|
| August 8, 2023 |
Form of Change in Control and Severance Agreement Exhibit 10.6 CHANGE-IN-CONTROL AND SEVERANCE AGREEMENT THIS CHANGE-IN-CONTROL AND SEVERANCE AGREEMENT (this “Agreement”), initially entered into by and between Tabula Rasa HealthCare, Inc., a Delaware corporation (the “Company”) and [] (the “Executive” and collectively with the Company referred to herein as the “Parties)” on [] (the “Effective Date”). WHEREAS, this Agreement replaces and supersede |
|
| August 8, 2023 |
Form of Performance Stock Unit Award Agreement Exhibit 10.5 TABULA RASA HEALTHCARE, INC. 2016 OMNIBUS INCENTIVE COMPENSATION PLAN PERFORMANCE STOCK UNIT SUMMARY OF GRANT Tabula Rasa Healthcare, Inc., a Delaware corporation (the “Company”), pursuant to its 2016 Omnibus Incentive Compensation Plan (the “Plan”), hereby grants to the individual listed below (the “Participant”), this performance stock unit grant representing the target number of st |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 7, 2023 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| August 7, 2023 |
Exhibit 10.1 VOTING AND SUPPORT AGREEMENT This Voting and Support Agreement (this “Agreement”) is made and entered into as of August 5, 2023 (the “Agreement Date”), by and among Tabula Rasa HealthCare, Inc., a Delaware corporation (“Company”), Locke Buyer, LLC, a Delaware limited liability company (“Parent”), and the Persons listed on Schedule A and the signature pages hereto (each, a “Stockholder |
|
| August 7, 2023 |
false000165156100016515612023-08-052023-08-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 7, 2023 |
Exhibit 99.1 Press Release Tabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex Needs $10.50 Per Share All-Cash Transaction Represents a Significant Premium for Tabula Rasa Stockholders Combination of Two Highly Complementary Companies to Benefit Patients, Providers and Payers with First of its Kind Risk |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| August 7, 2023 |
Press release of Tabula Rasa HealthCare, Inc. issued August 7, 2023 Exhibit 99.1 Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J., August 7, 2023 – Tabula Rasa HealthCare, Inc.® (Nasdaq:TRHC) (“TRHC” or the “Company”), a leading healthcare company advancing personalized, comprehens |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 7, 2023 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| August 7, 2023 |
Press Release dated August 7, 2023 Exhibit 99.1 Press Release Tabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex Needs $10.50 Per Share All-Cash Transaction Represents a Significant Premium for Tabula Rasa Stockholders Combination of Two Highly Complementary Companies to Benefit Patients, Providers and Payers with First of its Kind Risk |
|
| August 7, 2023 |
Exhibit 99.1 Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J., August 7, 2023 – Tabula Rasa HealthCare, Inc.® (Nasdaq:TRHC) (“TRHC” or the “Company”), a leading healthcare company advancing personalized, comprehens |
|
| August 7, 2023 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER By and Among LOCKE BUYER, LLC, LOCKE MERGER SUB, INC. and TABULA RASA HEALTHCARE, INC. Dated as of August 5, 2023 TABLE OF CONTENTS Page ARTICLE I The Merger SECTION 1.01. The Merger 2 SECTION 1.02. Closing 2 SECTION 1.03. Effective Time 3 SECTION 1.04. Effects of the Merger 3 SECTION 1.05. Certificate of Incorporation and Bylaws of the Surviving Corporatio |
|
| August 7, 2023 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER By and Among LOCKE BUYER, LLC, LOCKE MERGER SUB, INC. and TABULA RASA HEALTHCARE, INC. Dated as of August 5, 2023 TABLE OF CONTENTS Page ARTICLE I The Merger SECTION 1.01. The Merger 2 SECTION 1.02. Closing 2 SECTION 1.03. Effective Time 3 SECTION 1.04. Effects of the Merger 3 SECTION 1.05. Certificate of Incorporation and Bylaws of the Surviving Corporatio |
|
| August 7, 2023 |
Exhibit 10.1 VOTING AND SUPPORT AGREEMENT This Voting and Support Agreement (this “Agreement”) is made and entered into as of August 5, 2023 (the “Agreement Date”), by and among Tabula Rasa HealthCare, Inc., a Delaware corporation (“Company”), Locke Buyer, LLC, a Delaware limited liability company (“Parent”), and the Persons listed on Schedule A and the signature pages hereto (each, a “Stockholder |
|
| August 7, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 5, 2023 Tabula Rasa HealthCare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37888 46-5726437 (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 1, 2023 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commis |
|
| June 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 9, 2023 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| May 17, 2023 |
Exhibit 99.1 Copyright © 2023, Tabula Rasa HealthCare, Inc., All Rights Reserved. These materials are confidential and proprietary information of Tabula Rasa HealthCare, Inc. and may not be reproduced in whole or in part without the written consent of Tabula Rasa HealthCare, Inc. | NASDAQ – TRHC. Investor Presentation Tabula Rasa HealthCare May 2023 NASDAQ: TRHC Copyright © 2023 Tabula Rasa Health |
|
| May 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 17, 2023 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| May 9, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 Tab |
|
| May 8, 2023 |
Exhibit 99.1 Tabula Rasa HealthCare Reports First Quarter 2023 Financial Results First Quarter Results Show Benefits of Consistent Execution on Financial and Strategic Objectives First Quarter Revenue Growth of 32% Compared to First Quarter 2022 Raises Full Year 2023 Revenue and Adjusted EBITDA Guidance MOORESTOWN, N.J., May 8, 2023 /PRNewswire/ – Tabula Rasa HealthCare, Inc.® (Nasdaq:TRHC) (“TRHC |
|
| May 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2023 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) 46- |
|
| April 28, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted b |
|
| April 13, 2023 |
Exhibit 99.1 Tabula Rasa HealthCare Provides Corporate Updates Appoints Brian Adams as President and Chief Executive Officer and a Member of the Board of Directors, Effective Immediately Appoints Richard W. Rew II as Chief Legal Officer and Corporate Secretary Announces Preliminary Unaudited First Quarter 2023 Revenue Exceeding Guidance MOORESTOWN, N.J., April 13, 2023 – Tabula Rasa HealthCare, In |
|
| April 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 12, 2023 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commis |
|
| April 13, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted b |
|
| March 10, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 Tabula Rasa Hea |
|
| March 10, 2023 |
Form of Indemnification Agreement Exhibit 10.2 INDEMNIFICATION AGREEMENT This Indemnification Agreement, effective as of [●], 20[●] (this “Agreement”), is made by and between Tabula Rasa HealthCare, Inc., a Delaware corporation (the “Company”), and [●] (“Indemnitee”). RECITALS: A.The Company desires to attract and retain the services of highly qualified individuals as directors and officers. B.Competent and experienced persons are |
|
| March 10, 2023 |
Exhibit 21.1 Tabula Rasa HealthCare, Inc. Subsidiaries The following are the Company’s subsidiaries as of December 31, 2022 and the states or jurisdictions in which they are organized; provided, however, the names of particular subsidiaries have been omitted because, considered in the aggregate as a single subsidiary, they would not constitute, as of December 31, 2022, a “significant subsidiary” a |
|
| March 10, 2023 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Tabula Rasa HealthCare, Inc. |
|
| March 10, 2023 |
Exhibit 10.59 CERTAIN SCHEDULES AND EXHIBITS HAVE BEEN OMITTED PURSUANT TO ITEM 601(a)(5) OF REGULATION S-K. IN ADDITION, PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO ITEM 601(b)(2) of REGULATION S-K BECAUSE THEY (i) ARE NOT MATERIAL AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. THE COMPANY AGREES TO FURNISH SUPPLEMENTALLY TO THE COMMISSION AN UNREDAC |
|
| March 10, 2023 |
Exhibit 10.60 CERTAIN SCHEDULES AND EXHIBITS HAVE BEEN OMITTED PURSUANT TO ITEM 601(a)(5) OF REGULATION S-K. IN ADDITION, PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO ITEM 601(b)(2) of REGULATION S-K BECAUSE THEY (i) ARE NOT MATERIAL AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. THE COMPANY AGREES TO FURNISH SUPPLEMENTALLY TO THE COMMISSION AN UNREDAC |
|
| March 10, 2023 |
As filed with the Securities and Exchange Commission on March 10, 2023 As filed with the Securities and Exchange Commission on March 10, 2023 Registration No. |
|
| March 6, 2023 |
Exhibit 99.1 Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results Fourth Quarter Concludes Successful Transformational Year, With Company Sharpening Focus and Laying a Foundation for Sustainable, Profitable Growth Recently Completed Sales of SinfoníaRx and DoseMe Shares Full Year 2023 Revenue Guidance and Adjusted EBITDA Guidance MOORESTOWN, N.J., March 6, 2023 /PRNew |
|
| March 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 6, 2023 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) 4 |
|
| February 9, 2023 |
TRHC / Tabula Rasa HealthCare Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: Tabula Rasa HealthCare Inc. Title of Class of Securities: Common Stock CUSIP Number: 873379101 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| January 17, 2023 |
Exhibit 99.1 Tabula Rasa HealthCare Announces Preliminary Estimated Fourth Quarter 2022 Revenues From Continuing Operations Reports Preliminary Estimated Revenue from Continuing Operations of $82.0 - $83.0 Million for the Fourth Quarter of 2022, Continuing Strong 2022 Revenue Performance as Company Focuses on Core Business MOORESTOWN, N.J., January 17, 2023 /PRNewswire/ - Tabula Rasa HealthCare, I |
|
| January 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 17, 2023 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Comm |
|
| November 4, 2022 |
Exhibit 10.9 INDEMNIFICATION AGREEMENT This Indemnification Agreement, effective as of September 13, 2022 (this “Agreement”), is made by and between Tabula Rasa HealthCare, Inc., a Delaware corporation (the “Company”) and Jonathan Schwartz (“Indemnitee”). RECITALS: A.The Company desires to attract and retain the services of highly qualified individuals as directors, officers, employees and agents. |
|
| November 4, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 |
|
| November 4, 2022 |
Form of 2022 Performance Stock Unit Award Agreement Exhibit 10.8 TABULA RASA HEALTHCARE, INC. 2016 OMNIBUS INCENTIVE COMPENSATION PLAN PERFORMANCE STOCK UNIT SUMMARY OF GRANT Tabula Rasa Healthcare, Inc., a Delaware corporation (the “Company”), pursuant to its 2016 Omnibus Incentive Compensation Plan (the “Plan”), hereby grants to the individual listed below (the “Participant”), this performance stock unit grant representing the target number of st |
|
| November 3, 2022 |
Tabula Rasa HealthCare Reports Third Quarter 2022 Results Exhibit 99.1 Tabula Rasa HealthCare Reports Third Quarter 2022 Results ? ? Revenue from continuing operations of $77.1 million increased 14% vs. a year ago ? GAAP net loss from continuing operations of $25.9 million vs. $11.8 million a year ago ? Adjusted EBITDA from continuing operations of $2.1 million vs. $3.1 million a year ago ? Cash of $80.8 million as of September 30, 2022, vs. $26.5 millio |
|
| November 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? ? ? ? FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 3, 2022 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) ? ? ? ? ? ? ? ? ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) |
|
| October 11, 2022 |
EXHIBIT 99.1 TRHC Adds Ron Mitchell to its Board of Directors Ron Mitchell, Co-Founder and CEO of Humanity Health, joins Board of Directors MOORESTOWN, N.J., (October 11, 2022) - Tabula Rasa HealthCare, Inc.â (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that Ron Mitchell, co-founder and Chief Executive Officer of Humanity Hea |
|
| October 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 6, 2022 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commi |
|
| September 14, 2022 |
Exhibit 10.3 EXECUTIVE TRANSITION AND SEPARATION AGREEMENT This Executive Transition and Separation Agreement (this ?Agreement?), is entered into as of the date set forth on the signature page below (the ?Execution Date?), by and between Dr. Orsula V. Knowlton (?you?) and Tabula Rasa Healthcare, Inc. (together with its wholly owned subsidiaries and affiliates, the ?Company?). BACKGROUND WHEREAS, y |
|
| September 14, 2022 |
EX-99.1 7 tm2225741d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Tabula Rasa HealthCare Announces Cooperation Agreement with Indaba Capital Management to Refresh the Company’s Leadership and Board of Directors Agreement Also Provides for Enhancements to the Company’s Corporate Governance, Including a Commitment to Propose a De-Classification of the Board at the 2023 Annual Meeting MOORESTOWN, N.J., (Sept |
|
| September 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 3)1 Tabula Rasa HealthCare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) Darren |
|
| September 14, 2022 |
Exhibit 10.5 CONSULTING SERVICES AGREEMENT This CONSULTING SERVICES AGREEMENT (this ?Agreement?), is made as of this 13th day of September, 2022 (?Effective Date?), by and between Dr. Orsula V. Knowlton (?Consultant?) and Tabula Rasa Healthcare, Inc. (?Company?). W I T N E S S E T H: WHEREAS, Consultant previously served as the President and Chief New Business & Marketing Officer of Company (?Pres |
|
| September 14, 2022 |
Exhibit 10.4 CONSULTING SERVICES AGREEMENT This CONSULTING SERVICES AGREEMENT (this ?Agreement?), is made as of this 13th day of September, 2022 (?Effective Date?), by and between Dr. Calvin H. Knowlton (?Consultant?) and Tabula Rasa Healthcare, Inc. (?Company?). W I T N E S S E T H: WHEREAS, Consultant previously served as the Chief Executive Officer of Company (?CEO?) of Company; WHEREAS, Consul |
|
| September 14, 2022 |
Exhibit 99.2 Tabula Rasa HealthCare Announces Leadership Transition Drs. Calvin H. Knowlton and Orsula V. Knowlton to retire from the Company Co-President Brian Adams Named Interim CEO Director Michael Purcell Named Independent Board Chairman MOORESTOWN, N.J., (September 14, 2022) - Tabula Rasa HealthCare, Inc.? (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use |
|
| September 14, 2022 |
Exhibit 10.1 COOPERATION AGREEMENT This Cooperation Agreement (this ?Agreement?), effective as of September 13, 2022 (the ?Effective Date?), is entered into by and between Tabula Rasa HealthCare, Inc., a Delaware corporation (the ?Company?), and Indaba Capital Management, L.P. (?Indaba?). Indaba and each of its Affiliates (as defined below) are collectively referred to as the ?Investors.? The Comp |
|
| September 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 13, 2022 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Co |
|
| September 14, 2022 |
Exhibit 10.2 EXECUTIVE TRANSITION AND SEPARATION AGREEMENT This Executive Transition and Separation Agreement (this ?Agreement?), is entered into as of the date set forth on the signature page below (the ?Execution Date?), by and between Dr. Calvin H. Knowlton (?you?) and Tabula Rasa Healthcare, Inc. (together with its wholly owned subsidiaries and affiliates, the ?Company?). BACKGROUND WHEREAS, y |
|
| August 5, 2022 |
Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 5, 2022 |
Form of Restricted Stock Agreement ? Exhibit 10.5 ? TABULA RASA HEALTHCARE, INC. 2016 OMNIBUS INCENTIVE COMPENSATION PLAN RESTRICTED STOCK SUMMARY OF GRANT Tabula Rasa Healthcare, Inc., a Delaware corporation (the ?Company?), pursuant to its 2016 Omnibus Incentive Compensation Plan (the ?Plan?), hereby grants to the individual listed below (the ?Participant?), restricted stock of the Company (?Company Stock?) that may become vested |
|
| August 5, 2022 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 1, 2022 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of In |
|
| August 5, 2022 |
TABULA RASA HEALTHCARE, INC. UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.2 TABULA RASA HEALTHCARE, INC. UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Overview On August 1, 2022, Tabula Rasa HealthCare, Inc., a Delaware corporation (the ?Company?) and Tabula Rasa HealthCare Group, Inc. a Delaware corporation and wholly-owned subsidiary of the Company (?Seller?), completed the previously-announced divestiture of Seller?s unincorporated PrescribeWellnes |
|
| August 4, 2022 |
Tabula Rasa HealthCare Reports Second Quarter 2022 Results Exhibit 99.1 Tabula Rasa HealthCare Reports Second Quarter 2022 Results ? ? Revenue from continuing operations of $72.6 million increased 13% vs. a year ago, driven by CareVention HealthCare revenue growth of 17%. ? GAAP net loss from continuing operations of $12.7 million vs. $14.1 million a year ago and $20.4 million in Q1 2022. ? Adjusted EBITDA from continuing operations of $2.1 million vs. $3 |
|
| August 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? ? ? ? FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 4, 2022 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) ? ? ? ? ? ? ? ? ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) 0 |
|
| August 1, 2022 |
Exhibit 99.1 Tabula Rasa HealthCare Completes Sale of PrescribeWellness to Transaction Data Systems for $140 Million MOORESTOWN, N.J., (August 1, 2022) - Tabula Rasa HealthCare, Inc.? (?TRHC? or the ?Company?) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, announced today that it completed the previously announced sale of its PrescribeWellness busine |
|
| August 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 1, 2022 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commis |
|
| July 28, 2022 |
Indaba Capital Management, L.P. One Letterman Drive Building D, Suite 700 San Francisco, CA 94129 Exhibit 99.1 Indaba Capital Management, L.P. One Letterman Drive Building D, Suite 700 San Francisco, CA 94129 July 27, 2022 Tabula Rasa HealthCare, Inc. 228 Strawbridge Drive, Suite 100 Moorestown, New Jersey 08057 Attn: Brian W. Adams, Co-President and Secretary Re: Demand for Books and Records Pursuant to 8 Del. C. ? 220 Dear Mr. Adams: Indaba Capital Management, L.P., a Delaware limited partne |
|
| July 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 2)1 Tabula Rasa HealthCare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) Darren |
|
| July 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 25, 2022 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| July 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 TABULA RASA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 46-5726437 State of incorporation or organization) (I.R.S. Employer Identification No.) 228 Strawbridge |
|
| July 26, 2022 |
Tabula Rasa HealthCare Adopts Limited-Duration Stockholder Rights Plan EXHIBIT 99.1 Tabula Rasa HealthCare Adopts Limited-Duration Stockholder Rights Plan ? Responds to Substantial Stock Accumulation by Indaba Capital Management ? Protects Long-Term Value of All Stockholders? Investments in Tabula Rasa Moorestown, N.J. ? July 26, 2022 ? Tabula Rasa HealthCare, Inc. (?Tabula Rasa,? ?TRHC? or the ?Company?) (NASDAQ: TRHC), a leading healthcare technology company advanc |
|
| July 26, 2022 |
EXHIBIT 3.1 CERTIFICATE OF DESIGNATION OF SERIES A JUNIOR PARTICIPATING PREFERRED STOCK OF TABULA RASA HEALTHCARE, INC. (Pursuant to Section 151 of the Delaware General Corporation Law) Tabula Rasa HealthCare, Inc. (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of the Delaware, as amended (the ?DGCL?), hereby certifies that, pursuant to the |
|
| July 26, 2022 |
EXHIBIT 4.1 RIGHTS AGREEMENT by and between TABULA RASA HEALTHCARE, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, as Rights Agent, Dated as of July 25, 2022 TABLE OF CONTENTS Page Section 1. Certain Definitions 2 Section 2. Appointment of the Rights Agent 9 Section 3. Issuance of Rights Certificates 10 Section 4. Form of Rights Certificates 12 Section 5. Countersignature and Registration |
|
| July 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 1)1 Tabula Rasa HealthCare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) Darren |
|
| July 20, 2022 |
Tabula Rasa HealthCare Announces Preliminary Second Quarter 2022 Financial Results Exhibit 99.1 Tabula Rasa HealthCare Announces Preliminary Second Quarter 2022 Financial Results ? Reports Preliminary Revenue from Continuing Operations of $72 to $73 Million for the Second Quarter of 2022, Exceeding Prior Guidance Range and Continuing Strong 2022 Performance as Company Focuses on Core Business ? Company Comments on Public Statements by Indaba Capital Management Moorestown, N.J. ? |
|
| July 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 20, 2022 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| June 28, 2022 |
TRHC / Tabula Rasa HealthCare Inc / BlackRock Inc. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* TABULA RASA HEALTHCARE, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) David Maryles Managing Director, Legal and Compliance BlackRock, Inc. 55 East 52nd Street New York, N |
|
| June 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 20, 2022 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| June 21, 2022 |
Exhibit 2.2 ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT, dated as of June 18, 2022 (the ?Agreement?), is entered into by and between karmadata, Inc., a Delaware corporation (?Seller?), and Tabula Rasa HealthCare Group, Inc., a Delaware corporation (?Buyer?). Seller and Buyer are each referred to herein as a ?Party? and collectively as the ?Parties.? RECITALS WHEREAS, Seller is a technol |
|
| June 21, 2022 |
Exhibit 99.1 Tabula Rasa HealthCare Agrees to Sell its PrescribeWellness Business to Transaction Data Systems The Companies also Agree to a Strategic Multi-Year Partnership MOORESTOWN, N.J., June 21, 2022 - Tabula Rasa HealthCare, Inc.? (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, announced today that it has entered into a definitive agreeme |
|
| June 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 18, 2022 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| June 21, 2022 |
Exhibit 2.1 ASSET PURCHASE AGREEMENT BY AND BETWEEN TABULA RASA HEALTHCARE GROUP, INC., Seller, and TRANSACTION DATA SYSTEMS, INC., Buyer and solely for purposes of sections 6.1, 7.12, 7.13 and 11.12 and article 10 TABULA RASA HEALTHCARE, INC. Dated as of June 18, 2022 TABLE OF CONTENTS Page Article 1 DEFINITIONS; CONSTRUCTION 1 1.1?????????????Definitions 1 1.2?????????????Construction 18 Article |
|
| June 21, 2022 |
TRHC / Tabula Rasa HealthCare Inc / BlackRock Inc. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* TABULA RASA HEALTHCARE, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) David Maryles Managing Director, Legal and Compliance BlackRock, Inc. 55 East 52nd Street New York, NY 10055 ( |
|
| June 16, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 10, 2022 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| June 10, 2022 |
TRHC / Tabula Rasa HealthCare Inc / MACQUARIE GROUP LTD - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Tabula Rasa Healthcare Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 873379101 (CUSIP Number) 6/10/2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| June 1, 2022 |
SC 13D 1 sc13d1012301406012022.htm THE SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 Tabula Rasa HealthCare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Cl |
|
| June 1, 2022 |
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) Exhibit 99.1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Schedule 13D (including additional amendments thereto) with respect to the shares of common stock, par value $0.0001 per share, of Tabula Rasa HealthCare, Inc. Thi |
|
| May 20, 2022 |
Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Schedule 13G (including additional amendments thereto) with respect to the shares of common stock, par value $0.0001 per share, of Tabula Rasa HealthCare, Inc. This Joint Filing Agreement s |
|
| May 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )1 Tabula Rasa HealthCare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) N/A (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| May 18, 2022 |
Sixth Amendment to Restricted Stock Agreement (Calvin Knowlton) Exhibit 10.1 SIXTH AMENDMENT TO RESTRICTED STOCK GRANT AGREEMENT This Sixth Amendment (this ?Amendment?) to the Restricted Stock Grant Agreement, dated September 28, 2016, between Tabula Rasa HealthCare, Inc. (the ?Company?) and Dr. Calvin Knowlton (the ?Grantee?), as previously amended on June 12, 2017, May 30, 2018, May 2, 2019, February 24, 2020, and November 29, 2021 (the ?Restricted Stock Gra |
|
| May 18, 2022 |
Sixth Amendment to Restricted Stock Agreement (Orsula Knowlton) Exhibit 10.2 SIXTH AMENDMENT TO RESTRICTED STOCK GRANT AGREEMENT This Sixth Amendment (this ?Amendment?) to the Restricted Stock Grant Agreement, dated September 28, 2016, between Tabula Rasa HealthCare, Inc. (the ?Company?) and Dr. Orsula Knowlton (the ?Grantee?), as previously amended on June 12, 2017, May 30, 2018, May 2, 2019, February 24, 2020, and November 29, 2021 (the ?Restricted Stock Gra |
|
| May 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 13, 2022 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| May 9, 2022 |
Exhibit 10.4 ? CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH ?[***]?. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF DISCLOSED. ? MASTER SERVICES AGREEMENT This Master Services Agreement (?MSA?) is made as of 8/30/2021 (the ?Effective Date?), by and bet |
|
| May 9, 2022 |
Exhibit 10.2 ? CHANGE-IN-CONTROL AND SEVERANCE AGREEMENT THIS CHANGE-IN-CONTROL AND SEVERANCE AGREEMENT (this ?Agreement?) is entered into on February 24, 2022, (the ?Effective Date?) by and between Tabula Rasa HealthCare, Inc., a Delaware corporation (the ?Company?) and Thomas Cancro (the ?Executive?), collectively referred to herein as the ?Parties.? ? NOW, THEREFORE, in consideration of the pre |
|
| May 9, 2022 |
Form of Performance Stock Unit Award Agreement ? Exhibit 10.3 ? TABULA RASA HEALTHCARE, INC. 2016 OMNIBUS INCENTIVE COMPENSATION PLAN PERFORMANCE STOCK UNIT SUMMARY OF GRANT Tabula Rasa HealthCare, Inc., a Delaware corporation (the ?Company?), pursuant to its 2016 Omnibus Incentive Compensation Plan (the ?Plan?), hereby grants to the individual listed below (the ?Participant?), this performance stock unit grant representing the target number o |
|
| May 9, 2022 |
Exhibit 10.1 ? February 2, 2022 Mr. Thomas Cancro, CPA, CFA [ ] ? ? Dear Thomas, It is my pleasure to extend the following amended offer of employment to you on behalf of Tabula Rasa HealthCare, Inc. (?TRHC? or the ?Company?). This offer is contingent upon your acceptance of the terms and conditions set forth below and in the TRHC?s Change-in-Control and Severance Agreement. Title:Chief Financial |
|
| May 9, 2022 |
Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 5, 2022 |
Tabula Rasa HealthCare Reports First Quarter 2022 Results EX-99.1 2 trhc-20220505xex99d1.htm EX-99.1 Exhibit 99.1 Tabula Rasa HealthCare Reports First Quarter 2022 Results ● First quarter 2022 revenue of $67.1 million from continuing operations includes CareVention HealthCare revenue of $66.3 million, up 19% vs. a year ago ● Planned sales of PrescribeWellness, SinfoníaRx, and DoseMe expected to add significant liquidity, reduce net debt, and provide fina |
|
| May 5, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? ? ? ? FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 5, 2022 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) ? ? ? ? ? ? ? ? ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) 001- |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| April 28, 2022 |
DEF 14A 1 tm223460d1def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| April 21, 2022 |
TRHC / Tabula Rasa HealthCare Inc / BlackRock Inc. - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* TABULA RASA HEALTHCARE, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) David Maryles Managing Director, Legal and Compliance BlackRock, Inc. 55 East 52nd Street New York, NY 1 |
|
| February 25, 2022 |
As filed with the Securities and Exchange Commission on February 25, 2022 As filed with the Securities and Exchange Commission on February 25, 2022 Registration No. |
|
| February 25, 2022 |
Exhibit 10.43 ? CHANGE-IN-CONTROL AND SEVERANCE AGREEMENT THIS CHANGE-IN-CONTROL AND SEVERANCE AGREEMENT (this ?Agreement?), initially entered into by and between Tabula Rasa HealthCare, Inc., a Delaware corporation (the ?Company?) and Brian W. Adams (the ?Executive? and collectively with the Company referred to herein as the ?Parties)? on January 1, 2018 (the ?Initial Effective Date?), is being a |
|
| February 25, 2022 |
Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2021 Results Exhibit 99.1 Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2021 Results ? ? Fourth quarter and full year 2021 revenue grew 11% and 11% (7% on an organic basis), respectively, year-over-year. ? Fourth quarter and full year 2021 CareVention HealthCare revenue grew 16% and 20% (14% on an organic basis), respectively, year-over-year. The positive trends in our key annual metrics for PACE |
|
| February 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 25, 2022 (February 24, 2022) TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (C |
|
| February 25, 2022 |
EX-FILING FEES 4 tm227318d1ex-filingfees.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Newly Registered Securities Security Type Security Class Title(1) Fee Calculation Rule Amount registered (2) Proposed maximum offering price per share (3) Proposed maximum aggregate offering |
|
| February 25, 2022 |
EX-21.1 3 trhc-20211231xex21d1.htm EX-21.1 Exhibit 21.1 Tabula Rasa HealthCare, Inc. Subsidiaries The following are the Company’s subsidiaries as of December 31, 2021 and the states or jurisdictions in which they are organized; provided, however, the names of particular subsidiaries have been omitted because, considered in the aggregate as a single subsidiary, they would not constitute, as of Dece |
|
| February 25, 2022 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 14, 2022 |
TRHC / Tabula Rasa HealthCare Inc / MACQUARIE GROUP LTD - SC 13G/A Passive Investment SC 13G/A 1 d248483dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Tabula Rasa Healthcare Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 873379101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| February 14, 2022 |
TRHC / Tabula Rasa HealthCare Inc / CREDIT SUISSE AG/ - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* Tabula Rasa HealthCare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| February 14, 2022 |
EX-99.1 2 ex991.htm EX-99.1 In accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998), this Statement is being filed by Credit Suisse AG (the "Bank"), a Swiss bank, on behalf of its subsidiaries to the extent that they conduct business as the Swiss Universal Bank, Asia Pacific, International Wealth Management, Global Markets, Investment Banking & Capital Markets |
|
| February 10, 2022 |
TRHC / Tabula Rasa HealthCare Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: Tabula Rasa HealthCare Inc. Title of Class of Securities: Common Stock CUSIP Number: 873379101 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| December 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 8, 2021 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of |
|
| November 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 29, 2021 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Com |
|
| November 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 18, 2021 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Com |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 8, 2021 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File |
|
| November 12, 2021 |
Exhibit 99.1 Tabula Rasa HealthCare Makes Key Organizational Changes as Part of Strategic Growth Plans TRHC has promoted Brian W. Adams to Co-President, bridging critical functions under his leadership MOORESTOWN, N.J., Nov. 8, 2021 /PRNewswire/ ? Tabula Rasa HealthCare, Inc.? (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, has announced import |
|
| November 5, 2021 |
Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? ? ? ? FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 4, 2021 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) ? ? ? ? ? ? ? ? ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) |
|
| November 4, 2021 |
Tabula Rasa HealthCare Reports Third Quarter 2021 Results Exhibit 99.1 Tabula Rasa HealthCare Reports Third Quarter 2021 Results ? ? Third quarter revenue grew 23% year-over-year to $86.6 million. ? Third quarter organic revenue growth of 17% compares with 1% during the first half of 2021. ? MedWise HealthCare software subscriptions revenue of $11.8 million increased 16% year-over-year and 17% on a sequential basis as compared to the second quarter of 20 |
|
| October 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 30, 2021 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Co |
|
| September 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 23, 2021 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Co |
|
| August 10, 2021 |
TRHC / Tabula Rasa HealthCare Inc / MACQUARIE GROUP LTD - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Tabula Rasa Healthcare Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 873379101 (CUSIP Number) July 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi |
|
| August 6, 2021 |
Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 6, 2021 |
As filed with the Securities and Exchange Commission on August 6, 2021 As filed with the Securities and Exchange Commission on August 6, 2021 Registration No. |
|
| August 5, 2021 |
Tabula Rasa HealthCare Reports Second Quarter 2021 Results Exhibit 99.1 Tabula Rasa HealthCare Reports Second Quarter 2021 Results ? ? MOORESTOWN, N.J., August 5, 2021 /PRNewswire/ - Tabula Rasa HealthCare, Inc. (?TRHC?) (Nasdaq: TRHC), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the second quarter ended June 30, 2021. ? ?The continued strong recovery in PACE and our CareVention Healt |
|
| August 5, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? ? ? ? FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 5, 2021 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) ? ? ? ? ? ? ? ? ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) 0 |
|
| June 17, 2021 |
Tabula Rasa HealthCare, Inc. Employee Stock Purchase Plan Exhibit 10.1 TABULA RASA HEALTHCARE, INC. EMPLOYEE STOCK PURCHASE PLAN I. PURPOSE OF THE PLAN This Employee Stock Purchase Plan is intended to promote the interests of Tabula Rasa Healthcare, Inc., a Delaware corporation, by providing eligible employees with the opportunity to acquire a proprietary interest in the Corporation through participation in an employee stock purchase plan designed to qua |
|
| June 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 11, 2021 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37888 46-5726437 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 7, 2021 |
Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? ? ? ? FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2021 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) ? ? ? ? ? ? ? ? ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) 001- |
|
| May 6, 2021 |
Tabula Rasa HealthCare Reports First Quarter 2021 Results Exhibit 99.1 Tabula Rasa HealthCare Reports First Quarter 2021 Results ? ? MOORESTOWN, N.J., May 6, 2021 /PRNewswire/ - Tabula Rasa HealthCare, Inc. (?TRHC?) (Nasdaq:TRHC), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the first quarter ended March 31, 2021. ? ?I am pleased with the solid start to 2021 with first quarter revenue |
|
| April 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| April 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 26, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 26, 2021 |
As filed with the Securities and Exchange Commission on February 26, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 26, 2021 |
Exhibit 21.1 ? Tabula Rasa HealthCare, Inc. Subsidiaries The following are the Company?s subsidiaries as of December 31, 2020 and the states or jurisdictions in which they are organized; provided, however, the names of particular subsidiaries have been omitted because, considered in the aggregate as a single subsidiary, they would not constitute, as of December 31, 2020, a ?significant subsidiary? |
|
| February 24, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 23, 2021 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Numbe |
|
| February 24, 2021 |
Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2020 Results Exhibit 99.1 ? Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2020 Results ? ? MOORESTOWN, N.J., February 23, 2021 (PR NEWSWIRE) - Tabula Rasa HealthCare, Inc. (?TRHC?) (Nasdaq:TRHC), a healthcare technology company advancing the safe use of medications, today reported financial results for the fourth quarter and full year ended December 31, 2020. ? ?We finished a challenging 2020 wit |
|
| February 12, 2021 |
In accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998), this Statement is being filed by Credit Suisse AG (the "Bank"), a Swiss bank, on behalf of its subsidiaries to the extent that they conduct business as the Swiss Universal Bank, Asia Pacific, International Wealth Management, Global Markets, Investment Banking & Capital Markets and the Strategic Resolutio |
|
| February 12, 2021 |
SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 0)* Tabula Rasa Healthcare Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 873379101 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t |
|
| February 12, 2021 |
SC 13G 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Tabula Rasa HealthCare, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 873379101 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the |
|
| February 10, 2021 |
SC 13G/A 1 tv01929-tabularasahealthcare.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Tabula Rasa HealthCare Inc. Title of Class of Securities: Common Stock CUSIP Number: 873379101 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate bo |
|
| January 12, 2021 |
Exhibit 99.1 Tabula Rasa HealthCare Announces Preliminary Fourth Quarter and Full Year 2020 Unaudited Revenue and Select PACE Operating Metrics MOORESTOWN, N.J., January 12, 2021 - Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing safer use of medications, today announced preliminary, unaudited financial results and select PACE operating metrics for the fourth q |
|
| January 12, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 12, 2021 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number |
|
| December 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 18, 2020 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Numbe |
|
| December 22, 2020 |
Exhibit 10.1 TABULA RASA HEALTHCARE GROUP, INC., TABULA RASA HEALTHCARE, INC., CK SOLUTIONS, LLC, PERSONICA, LLC, TRHC TPA, LLC, AND PERSONIFILRX, LLC, as BORROWERS, WESTERN ALLIANCE BANK, as ADMINISTRATIVE AGENT, and REGIONS BANK, as DOCUMENTATION AGENT LOAN AND SECURITY AGREEMENT This LOAN AND SECURITY AGREEMENT is entered into as of December 18, 2020, by and among (i) TABULA RASA HEALTHCARE GRO |
|
| November 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 16, 2020 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Numbe |
|
| November 16, 2020 |
Exhibit 10.1 November 12, 2020 [] VIA E-MAIL Dear [], This letter agreement between you and Tabula Rasa HealthCare, Inc. (the “Company”) is intended to document the reduction of your base salary as a response to the unprecedented economic environment created by the novel coronavirus (“COVID-19”) (this “Agreement”). Except as provided below, this Agreement shall supplement and amend the Change-in-C |
|
| November 6, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 |
|
| November 3, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 3, 2020 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number |
|
| November 3, 2020 |
Tabula Rasa HealthCare Reports Third Quarter 2020 Results Exhibit 99.1 Tabula Rasa HealthCare Reports Third Quarter 2020 Results MOORESTOWN, N.J., November 3, 2020 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc. (“TRHC”) (Nasdaq:TRHC), a healthcare technology company advancing the field of medication safety, today reported financial results for the third quarter ended September 30, 2020. “We are pleased with the resilience and focus of our team during th |
|
| October 5, 2020 |
Exhibit 99.1 Tabula Rasa HealthCare Expands CareVention HealthCare Offerings with the Addition of PersonifilRx and Pharmastar MOORESTOWN, N.J., October 5, 2020 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced the acquisition of Personica, LLC and its subsidiaries PersonifilRx, Pharmast |
|
| October 5, 2020 |
Exhibit 10.1 LOAN AND SECURITY MODIFICATION AGREEMENT This Loan and Security Modification Agreement (this “Amendment”) is entered into as of October 5, 2020, by and among (i) TABULA RASA HEALTHCARE GROUP, INC., a Delaware corporation (“OpCo”), TABULA RASA HEALTHCARE, INC., a Delaware corporation (“Parent”), CK SOLUTIONS, LLC, a Delaware limited liability company (“CK Solutions”; Parent, OpCo and C |
|
| October 5, 2020 |
Exhibit 2.1 EXECUTION VERSION MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among TABULA RASA HEALTHCARE GROUP, INC., Tabula Rasa Healthcare, Inc., PERSONICA HOLDINGS, INC., peter c. farrow, robert tanner, michele bauer, luke johnson and Personica Holdings, Inc., as Seller Representative dated as of October 5, 2020 TABLE OF CONTENTS Page ARTICLE I Definitions 2 ARTICLE II Sale and Purchase of the |
|
| October 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 5, 2020 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) |
|
| September 9, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 2, 2020 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Numbe |
|
| September 9, 2020 |
Exhibit 10.1 LOAN AND SECURITY MODIFICATION AGREEMENT This Loan and Security Modification Agreement (this “Amendment”) is entered into as of September 2, 2020, by and among (i) TABULA RASA HEALTHCARE GROUP, INC., a Delaware corporation (“OpCo”), TABULA RASA HEALTHCARE, INC., a Delaware corporation (“Parent”), CK SOLUTIONS, LLC, a Delaware limited liability company (“CK Solutions”; Parent, OpCo and |
|
| August 6, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 Tabu |
|
| August 6, 2020 |
Exhibit 10.1 TWP Thrifty White Pharmacy Affiliated Pharmacy Program AFFILIATED PHARMACY AGREEMENT This Affiliated Pharmacy Agreement (“Agreement”), dated as of the 30th day of June, 2020, is between Thrifty Drug Stores, Inc., a Minnesota corporation (“Company”), and Tabula Rasa HealthCare Group, Inc., an affiliated pharmacy (“Retailer”). Whereas, the Company is in the business of providing goods, |
|
| August 6, 2020 |
Exhibit 10.2 TWP Thrifty White Pharmacy Affiliated Pharmacy Program AFFILIATED PHARMACY PHARMACEUTICAL SUPPLY PROGRAM This Pharmaceutical Program Supply Agreement (this “Agreement”) is effective as of July 1st, 2020 between Thrifty Drug Stores, Inc., a Minnesota corporation (the “Company”), and Tabua Rasa Healthcare Group, Inc., an affiliated pharmacy (“Retailer”). Company and Retailer may be refe |
|
| August 6, 2020 |
Exhibit 10.3 TWP Thrifty White Pharmacy Affiliated Pharmacy Program Retailer Addendum to Pharmaceutical Program Supply Agreement (High Volume) This Retailer Addendum to Pharmaceutical Program Supply Agreement (“Addendum”) is made effective as of June 30, 2020 (“Effective Date”) by and between Thrifty Drug Stores, Inc. (“Company”) and the undersigned pharmacy (“Retailer”). Company and Retailer are |
|
| August 4, 2020 |
Tabula Rasa HealthCare Reports Second Quarter 2020 Results Exhibit 99.1 Tabula Rasa HealthCare Reports Second Quarter 2020 Results MOORESTOWN, N.J., August 4, 2020 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today reported financial results for the second quarter ended June 30, 2020. Second Quarter 2020 Highlights ● Total revenue of $76.8 million, which i |
|
| August 4, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 4, 2020 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) |
|
| June 16, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 12, 2020 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) 4 |
|
| May 19, 2020 |
TRHC / Tabula Rasa HealthCare, Inc. / Knowlton Calvin H - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4) TABULA RASA HEALTHCARE, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 873379 101 (CUSIP Number) James W. McKenzie, Jr. Jeffrey P. Bodle Kevin S. Shmelzer Morgan, Lewis & Bockius LLP 1701 Market Street Phi |
|
| May 8, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 Tab |
|
| May 7, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 7, 2020 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) 46- |
|
| May 7, 2020 |
Tabula Rasa HealthCare Reports First Quarter 2020 Results Exhibit 99.1 Tabula Rasa HealthCare Reports First Quarter 2020 Results MOORESTOWN, N.J., May 7, 2020 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today reported financial results for the first quarter ended March 31, 2020. First Quarter 2020 Highlights · Total revenue of $72.8 million, near the hig |
|
| April 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| April 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| March 2, 2020 |
Exhibit 10.13 LOAN AND SECURITY MODIFICATION AGREEMENT This Loan and Security Modification Agreement (this “Amendment”), is entered into as of December 20, 2019, by and among (i) CAREKINESIS, INC., a Delaware corporation (“CareKinesis”), TABULA RASA HEALTHCARE, INC., a Delaware corporation (“Parent”), CAREVENTIONS, INC., a Delaware corporation (“Careventions”), CAPSTONE PERFORMANCE SYSTEMS, LLC, a |
|
| March 2, 2020 |
TRHC / Tabula Rasa HealthCare, Inc. S-8 - - FORM S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 46-5726437 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 228 Strawbridge Drive, Suite 100 Moorestown, NJ 08057 (8 |
|
| March 2, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 Tabula Rasa Hea |
|
| March 2, 2020 |
Description of Registrant’s Securities Exhibit 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following summary describes the common stock, par value $0.0001 per share, of Tabula Rasa HealthCare, Inc. (“TRHC,” “we,” “us,” and “our”), which are the only securities of TRHC registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended. The |
|
| March 2, 2020 |
Form of Director Stock Unit Agreement Exhibit 10.15 TABULA RASA HEALTHCARE, INC. 2016 OMNIBUS INCENTIVE COMPENSATION PLAN DIRECTOR SUMMARY OF STOCK UNIT GRANT Tabula Rasa Healthcare, Inc., a Delaware corporation (the “Company”), pursuant to its 2016 Omnibus Incentive Compensation Plan (the “Plan”), hereby grants to the individual listed below (the “Participant”), stock units with respect to the common stock of the Company (“Company St |
|
| March 2, 2020 |
Exhibit 21.1 Tabula Rasa HealthCare, Inc. Subsidiaries The following are the Company’s subsidiaries as of December 31, 2019 and the states or jurisdictions in which they are organized; provided, however, the names of particular subsidiaries have been omitted because, considered in the aggregate as a single subsidiary, they would not constitute, as of December 31, 2019, a “significant subsidiary” a |
|
| February 27, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2020 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Numbe |
|
| February 27, 2020 |
Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2019 Results Exhibit 99.1 Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2019 Results MOORESTOWN, N.J., February 27, 2020 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial results for the fourth quarter and full year ended December 31, 2019. Full Year 2019 Highlights · To |
|
| February 25, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 24, 2020 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Numbe |
|
| February 12, 2020 |
TRHC / Tabula Rasa HealthCare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Tabula Rasa HealthCare Inc Title of Class of Securities: Common Stock CUSIP Number: 873379101 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is f |
|
| November 8, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 |
|
| November 7, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 7, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number |
|
| November 7, 2019 |
Exhibit 99.1 Tabula Rasa HealthCare Announces Third Quarter 2019 Operating Results Third Quarter 2019 Revenue of $74.3 million, growth of 36% MOORESTOWN, N.J., November 7, 2019 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial results for the third quarter ended September 3 |
|
| August 9, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 Tabu |
|
| August 8, 2019 |
Exhibit 99.1 Tabula Rasa HealthCare Announces Second Quarter 2019 Operating Results Second Quarter 2019 Revenue of $76.3 million, growth of 57%; 2019 Guidance Increased MOORESTOWN, N.J., August 8, 2019 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial results for the second |
|
| August 8, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) |
|
| June 17, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 14, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) 4 |
|
| May 22, 2019 |
TRHC / Tabula Rasa HealthCare, Inc. / Knowlton Calvin H - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3) TABULA RASA HEALTHCARE, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 873379 101 (CUSIP Number) James W. McKenzie, Jr. Jeffrey P. Bodle Kevin S. Shmelzer Morgan, Lewis & Bockius LLP 1701 Market Street Phi |
|
| May 21, 2019 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 5, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commi |
|
| May 21, 2019 |
Exhibit 99.3 Contents Independent auditor’s report 1 Financial statements Balance sheets 2 Statements of operations 3 Statements of members’ equity 4 Statements of cash flows 5 Notes to financial statements 6-16 RSM US LLP Independent Auditor’s Report Board of Directors Prescribe Wellness, LLC Report on the Financial Statements We have audited the accompanying financial statements of Prescribe Wel |
|
| May 21, 2019 |
TABULA RASA HEALTHCARE, INC. UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS Exhibit 99.4 TABULA RASA HEALTHCARE, INC. UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS On March 5, 2019, Tabula Rasa HealthCare, Inc., a Delaware corporation (the “Company”), and TRHC PW Acquisition, LLC, a Nevada limited liability company and a wholly-owned subsidiary of the Company (“Merger Sub”), entered into, and consummated the transactions contemplated by, a Merger Agreement (the “Merge |
|
| May 10, 2019 |
Exhibit 10.2 LOAN AND SECURITY MODIFICATION AGREEMENT This Loan and Security Modification Agreement (this “Amendment”), is entered into as of March 5, 2019, by and among (i) CAREKINESIS, INC., a Delaware corporation (“CareKinesis”), TABULA RASA HEALTHCARE, INC., a Delaware corporation (“Parent”), CAREVENTIONS, INC., a Delaware corporation (“Careventions”), CAPSTONE PERFORMANCE SYSTEMS, LLC, a Dela |
|
| May 10, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 |
|
| May 10, 2019 |
Exhibit 10.11 AFFILIATED PHARMACY AGREEMENT THIS AFFILIATED PHARMACY AGREEMENT (“Agreement”), dated as of the 29th day of March 2019, is between Thrifty Drug Stores, Inc., a Minnesota corporation (“Company”), and Tabula Rasa HealthCare, Inc., an affiliated pharmacy (“Retailer”). WHEREAS, the Company is in the business of providing goods, including pharmaceuticals, and services to affiliated drug s |
|
| May 10, 2019 |
Exhibit 10.12 AFFILIATED PHARMACY PROGRAM PHARMACEUTICAL SUPPLY PROGRAM This Pharmaceutical Program Supply Agreement (this “Agreement”) is effective as of March 29, 2019 between Thrifty Drug Stores, Inc., a Minnesota corporation (the “Company”), and Tabula Rasa HealthCare, Inc., an affiliated pharmacy (“Retailer”). RECITALS: A.The Company and Retailer are parties to an Affiliated Pharmacy Agreemen |
|
| May 8, 2019 |
Exhibit 99.1 Tabula Rasa HealthCare Announces First Quarter 2019 Operating Results First Quarter 2019 Revenue of $61.0 million, growth of 39%; 2019 Guidance Reiterated MOORESTOWN, N.J., May 8, 2019 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial results for the first quar |
|
| May 8, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) 46- |
|
| May 2, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware 001-37888 46-5726437 (State or Other (Commission File (I.R.S. Employer Jurisdiction o |
|
| April 30, 2019 |
TRHC / Tabula Rasa HealthCare, Inc. DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| April 30, 2019 |
TRHC / Tabula Rasa HealthCare, Inc. DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| March 19, 2019 |
EX-99.1 3 a19-65202ex99d1.htm EX-99.1 Exhibit 99.1 DoseMe Holdings Pty Ltd ABN 23 168 742 336 Financial Statements For the three months ended September 30, 2018 TABLE OF CONTENTS Page Number Unaudited Consolidated Financial Statements of DoseMe Holdings Pty Ltd Independent Auditor’s Review Report 1 Unaudited Consolidated Balance Sheets as of September 30, 2018 and June 30, 2018 2 Unaudited Consoli |
|
| March 19, 2019 |
DoseMe Holdings Pty Ltd ABN 23 168 742 336 Financial Statements For the year ended June 30, 2018 Exhibit 99.2 DoseMe Holdings Pty Ltd ABN 23 168 742 336 Financial Statements For the year ended June 30, 2018 TABLE OF CONTENTS Page Number Audited Consolidated Financial Statements of DoseMe Holdings Pty Ltd Independent Auditor’s Report 1 Consolidated Balance Sheets as of June 30, 2018 and 2017 3 Consolidated Statements of Operations for the Years Ended June 30, 2018 and 2017 4 Consolidated State |
|
| March 19, 2019 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 31, 2018 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (C |
|
| March 19, 2019 |
TABULA RASA HEALTHCARE, INC. UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS Exhibit 99.3 TABULA RASA HEALTHCARE, INC. UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS On January 2, 2019, DM Acquisition Pty Ltd (“Purchaser”), a proprietary company limited by shares organized under the Laws of Australia and wholly-owned subsidiary of Tabula Rasa HealthCare, Inc., a Delaware corporation (“TRHC” or the “Company”), completed the acquisition of all of the outstanding share cap |
|
| March 14, 2019 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 14, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) |
|
| March 6, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 5, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) 4 |
|
| March 6, 2019 |
Exhibit 99.1 Tabula Rasa HealthCare Appoints New Member to its Board of Directors Rear Admiral Pamela Schweitzer, PharmD Joins Board of Medication Safety Company Moorestown, NJ (March 6, 2019) - Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, appointed former Assistant Surgeon General and Chief Pharmacist of the United States P |
|
| March 5, 2019 |
Tabula Rasa Acquisition of PrescribeWellness March 5, 2019 Exhibit 99.2 Tabula Rasa Acquisition of PrescribeWellness March 5, 2019 Legal Disclosure Forward-looking statements This presentation contains “forward-looking” statements that are based on our management’s beliefs and assumptions and on information currently available to management. Forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-lookin |
|
| March 5, 2019 |
EX-99.1 3 a19-58641ex99d1.htm EX-99.1 Exhibit 99.1 Tabula Rasa HealthCare Announces Acquisition of PrescribeWellness Expanding its Medication Risk Mitigation Offering MOORESTOWN, N.J., March 5, 2019 - Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that it has acquired PrescribeWellness (“PW”), a leadin |
|
| March 5, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 5, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Number) 4 |
|
| March 5, 2019 |
Exhibit 2.1 EXECUTION VERSION MERGER AGREEMENT dated as of March 5, 2019 by and among PRESCRIBE WELLNESS, LLC, TABULA RASA HEALTHCARE, INC., TRHC PW ACQUISITION, LLC, and FORTIS ADVISORS LLC, in its capacity as Holder Representative TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 1 ARTICLE II THE MERGER 12 2.1 Merger 13 2.2 Closing 13 2.3 Articles of Organization and Operating Agreement of th |
|
| March 4, 2019 |
TRHC / Tabula Rasa HealthCare, Inc. S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tabula Rasa HealthCare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 46-5726437 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 228 Strawbridge Drive, Suite 100 Moorestown, NJ 08057 (8 |
|
| March 1, 2019 |
Exhibit 10.11 LEASE AGREEMENT 228 Strawbridge Associates, LLC Landlord AND Tabula Rasa HealthCare, Inc. Tenant AT 228 Strawbridge Drive Moorestown, New Jersey Suite 100 – Phase II LEASE AGREEMENT INDEX § Section Page 1. Basic Lease Terms and Definitions 1 2. Premises 2 3. Use 3 4. Term; Possession 3 5. Rent 3 6. Operating Expenses; Property Taxes 3 7. Services 4 8. Insurance; Waivers; Indemnificat |
|
| March 1, 2019 |
Exhibit 2.6 EXECUTION VERSION STOCK PURCHASE AGREEMENT by and among TRHC MEC Holdings, llc, the Sellers (as defined herein), and mace wolf, as SellerS’ Representative dated as of October 19, 2018 ARTICLE I DEFINITIONS 1 ARTICLE II SALE AND PURCHASE OF THE SHARES 16 2.1 Sale and Purchase. 16 2.2 Estimated Closing Payment Statement. 17 2.3 Closing Payments. 17 2.4 Purchase Price Adjustment. 18 2.5 C |
|
| March 1, 2019 |
Exhibit 21.1 Tabula Rasa HealthCare, Inc. Subsidiaries NAME JURISDICTION OF ORGANIZATION OR INCORPORATION CareKinesis, Inc. Delaware Capstone Performance Systems, LLC Delaware Cognify, LLC Delaware eClusive L.L.C. Minnesota Mediture LLC Minnesota Medliance, LLC Arizona J.A. Robertson, Inc. California TRSHC Holdings, LLC Delaware SinfoníaRx, Inc. Arizona TRHC MEC Holdings, LLC Delaware TRHC DM Hold |
|
| March 1, 2019 |
Exhibit 10.13 LEASE AGREEMENT 228 Strawbridge Associates, LLC Landlord AND Tabula Rasa HealthCare, Inc. Tenant AT 228 Strawbridge Drive Moorestown, New Jersey Suite 300 — Phase III LEASE AGREEMENT INDEX § Section Page 1. Basic Lease Terms and Definitions 2 2. Premises 3 3. Use 4 4. Term; Possession 4 5. Rent 4 6. Operating Expenses; Property Taxes 4 7. Services 5 8. Insurance; Waivers; Indemnifica |
|
| March 1, 2019 |
TRHC / Tabula Rasa HealthCare, Inc. 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37888 Tabula Rasa Hea |
|
| March 1, 2019 |
Exhibit 10.12 LEASE AGREEMENT 228 Strawbridge Associates, LLC Landlord AND Tabula Rasa HealthCare, Inc. Tenant AT 228 Strawbridge Drive Moorestown, New Jersey LEASE AGREEMENT INDEX § Section Page 1. Basic Lease Terms and Definitions 2 2. Premises 3 3. Use 4 4. Term; Possession 4 5. Rent 4 6. Operating Expenses; Property Taxes 4 7. Services 5 8. Insurance; Waivers; Indemnification 5 9. Maintenance |
|
| February 28, 2019 |
Exhibit 99.1 Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2018 Operating Results 2018 Revenue of $204.3 million, growth of 53%; 4Q 2018 Revenue of $57.3 million, growth of 32% Provides initial 2019 financial outlook MOORESTOWN, N.J., February 28, 2019 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medi |
|
| February 28, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 28, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37888 (Commission File Numbe |
|
| February 14, 2019 |
TRHC / Tabula Rasa HealthCare, Inc. / Radius Venture Partners III, LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. |
|
| February 12, 2019 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Tabula Rasa HealthCare Announces Closing of Offering of 1.75% Convertible Notes and Exercise in Full of Option to Purchase Additional Notes MOORESTOWN, N.J., February 12, 2019 — Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) (“TRHC”) today announced the closing of its previously announced offering of $325 million principal amount of 1.75% convertible senior subordina |
|
| February 12, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 7, 2019 TABULA RASA HEALTHCARE, INC. (Exact Name of Registrant Specified in Charter) Delaware 001-37888 46-5726437 (State or Other (Commission File (I.R.S. Employer Jurisdict |
